Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125691552 | 12569155 | 2 | F | 20160614 | 20160715 | 20160719 | 20160721 | EXP | HR-JNJFOC-20160713489 | JANSSEN | 18.00 | YR | T | F | Y | 0.00000 | 20160721 | MD | HR | HR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125691552 | 12569155 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 20272 | UNSPECIFIED | ||||||||
125691552 | 12569155 | 2 | SS | BIPERIDEN | BIPERIDEN | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125691552 | 12569155 | 3 | SS | NORMABEL | DIAZEPAM | 1 | Oral | U | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125691552 | 12569155 | 1 | Product used for unknown indication |
125691552 | 12569155 | 2 | Product used for unknown indication |
125691552 | 12569155 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125691552 | 12569155 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125691552 | 12569155 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125691552 | 12569155 | 1 | 20160614 | 0 | ||
125691552 | 12569155 | 2 | 20160614 | 0 | ||
125691552 | 12569155 | 3 | 20160614 | 0 |